Navigation Links
2011 International Conference on TomoTherapy (ICT) Highlights Widespread Acceptance of the Benefits of Daily Image-Guided IMRT
Date:9/23/2011

SUNNYVALE, Calif., Sept. 23, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced details of the 2011 International Conference on TomoTherapy (ICT), which took place September 16-17, 2011 hosted by the University of Heidelberg, Germany's oldest University and world famous research center for cancer and microbiology. University of Heidelberg was the first institution in Germany to adopt the TomoTherapy® System for daily image-guided, intensity-modulated radiation therapy (DIG-IMRT) with its installation in 2006. The university started treating patients on their second TomoTherapy System in January 2011.

The ICT provides a forum to discuss the clinical capabilities, innovative concepts and ongoing clinical trials for TomoTherapy technology. In attendance this year were approximately 200 participants from around the world, composed of users and non-users of the TomoTherapy System.

Keynote addresses were given by Prof. Steve Webb, Professor of Radiological Physics from Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, UK, and conference chair Prof. Jurgen Debus, Head of the Department of Radiation Oncology, University of Heidelberg. Prof. Webb's talk, titled 'Rotation Radiotherapy: A Revolution in Radiotherapy' reviewed the evolution of IMRT and highlighted the superiority of the dose modulation techniques available today. Prof. Debus' presentation 'Photons meet Particles' addressed the potential new standards particles can set in the future, underlining the limitations and open questions of this technique today. He insisted on the fact that it is not about "either photons or particles", but about finding the right balance and indications.

"We were extremely pleased with the strong international rep
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
2. Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens Symposium
3. Chindex International, Inc. to Attend Nomura Healthcare Corporate Day
4. International House and Bayer HealthCare Partner to Prepare Women for Leadership Positions
5. Medizone International Tightens Noose on Food-Borne Pathogens, Bed Bugs and MRSA
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at UBS Global Life Sciences Conference
7. International Isotopes Inc Announces Conference Call to Give an Update on the Companys General Business Status
8. SUTIMCo International Inc. to Attend 125th AOAC Annual Meeting
9. New International Pharmaceutical Company Pro Bono Bio Launched Today
10. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
11. VWR International, LLC Acquires INTERNATIONAL P.B.I. S.p.A.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 Australian biomarker discovery ... US trial of its MiStat™ prostate cancer screening test, ... regulatory approval upon completion. Minomic,s proprietary MiStat™ ... presence of a proprietary biomarker known as the MIL-38 ... prostate cancer cells. Researchers at 11 ...
(Date:9/18/2014)...  Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical ... RNA viruses, today announced a research collaboration with ... testing of the Company,s lead compound, SB 9200, ... against which currently there are no effective antiviral ... proprietary Small Molecule Nucleic Acid Hybrid (SMNH) ...
(Date:9/18/2014)... /CNW/ - A new expert panel report, Improving Medicines ... released today by the Council of Canadian Academies, addresses ... children. Each year about half of Canada,s ... prescription drug. Much of this prescribing is done off-label ... potential health risks. Children have historically been ...
Breaking Medicine Technology:Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
... major personalized medicine advances will create therapies that are so ... industry to gain access, the inventor of the DNA gene ... Personalized Health Care National Conference . ... Biology, said personalized medicine,s first "killer apps" - therapies that ...
... focus on complex cases, facility called ,future of hospital care, ... Dallas announces the opening of the Hamon Tower, the largest ... to intensive care for the region,s most critically ill patients. ... and new clinical programs for ICU patients, Hamon Tower is ...
Cached Medicine Technology:Personalized Medicine 'Killer Apps' Will Transform Care Model 2Hamon Tower Features Critical Care Advances, Potential for Reduced Costs 2
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, 2014 ... antidepressant can quickly alter the way brain cells communicate with ... Sept. 18 in Current Biology , are a ... antidepressants. Experts said the hope is to eventually be able ... from a drug -- and which people would fare better ...
(Date:9/18/2014)... 19, 2014 In 2003, ... Mission (Misión Barrio Adentro), which it hoped ... system (see Section 6.1.3.). In 2009, it ... Autonomous Service of Pharmaceutical Elaborations (Servicio Autónomo ... provides medicines at a cheaper rate than ...
(Date:9/18/2014)... 18, 2014 Ben Quirk, CEO of ... Jr. Leadership Award by the Savannah Science Seminar in ... wellness throughout the nation and especially in Savannah. , ... said Ben. “The Savannah Science Seminar is an amazing ... multiple generations have gone through the program,” he added. ...
(Date:9/18/2014)... convene a one-day conference at the Milken Institute School ... September 25, 2014 to discuss the Global Health Security ... purpose of this event is to invite discussion of ... years, including action plans to curtail the current deadly ... GHSA, international organizations and more than 50 countries have ...
(Date:9/18/2014)... N.C. Dangerous new pathogens such as the Ebola ... ancient scourges such as the bubonic plague are still ... responds to infections. , In a study published online ... researchers at Duke Medicine and Duke-NUS Graduate Medical School ... bubonic plague hitchhike on immune cells in the lymph ...
Breaking Medicine News(10 mins):Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 2Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2Health News:New insights on an ancient plague could improve treatments for infections 2
... Orissa government has ordered administrations of all 30 districts to ... three days.// ,The officials were Thursday asked to ... senior health department official. ,These would then be ... government does not have testing facilities to confirm the presence ...
... safety lawyer, writes about why it is essential for us ... that there is a major defect in the food safety ... people affected or even killed by contaminated food products from ... it prevents our society from knowing the source of our ...
... of NSAID by women in their first trimester could ... ,Non-steroidal anti-inflammatory drugs, NSAIDs, Cardiac septal defects, Journal ... Congenital abnormality, Diabetes ,Women who take non-steroidal ... more likely to give birth to babies with congenital ...
... say that a commonly used HIV drug may be useful ... be used in prevention of the cancer and could be ... and his colleagues said that such a cream could prove ... lesions. However no clinical trials have begun as yet. ...
... hundreds of resident doctors in Delhi who had gone on ... agitation //for the next three months with the reservation bill ... the parliament has referred the reservation bill to the standing ... being. The bill will be placed in the floor of ...
... the University of Pennsylvania have disclosed that a specific ... of changing into bone, muscle, neurons or other// types ... environment. , ,The researchers found that ... bone marrow, are soliciting tangible clues from their local ...
Cached Medicine News:Health News:Importance of knowing the source of our food 2Health News:NSAIDs In First trimester Linked To Congenital Anomalies In Babies 2Health News:Medicos Suspends Anti-quota Stir 2Health News:Adult stem cells are sensitive to responses from the environment 2
85 left angled suture passer....
45 right angled suture passer....
... a fully-absorbable soft tissue anchor constructed ... and provides fixation strength comparable to ... anchor retains strength throughout the soft ... leaving no permanent foreign material presence. ...
... a fully absorbable soft tissue anchor designed ... dynamic engagement into cancellous bone, its broad ... tip length provide significant resistance to pullout ... material anchor construction provides the benefits of ...
Medicine Products: